Ovarian cancer 'breakthrough' drug prevents disease returning for years

Ovarian cancer 'breakthrough' drug prevents disease returning for years

A new ovarian cancer treatment dramatically reduces the chances of the disease returning, a study has shown. Doctors have hailed the results of a “breakthrough” trial which they say opens the possibility that many more women suffering the hard-to-treat disease can be cured. Ovarian cancer has one of the worst survival rates, with just 35 […]

Immunotherapy Shows Promise in Combating Aggressive Breast Cancer

Immunotherapy Shows Promise in Combating Aggressive Breast Cancer

By Denise Grady, New York Times Women with an aggressive type of breast cancer lived longer if they received immunotherapy plus chemotherapy, rather than chemo alone, a major study has found. The results are expected to change the standard of care for women like those in the clinical trial, who had advanced cases of “triple-negative” […]

Roche takes on Loxo, Bayer in gene-defined cancer class

Roche takes on Loxo, Bayer in gene-defined cancer class

MUNICH (Reuters) – Roche’s entrectinib cancer pill was shown to shrink tumors in 57 percent of patients within a group that can only be identified via genetic profiling, as the Swiss drugmaker challenges an alliance of Bayer and Loxo Oncology in a new targeted treatment area. FILE PHOTO: The logo of Swiss pharmaceutical company Roche […]

Drug mix 'extends life of breast cancer patients'

Drug mix 'extends life of breast cancer patients'

Combining the newly developed drug palbociclib with hormone therapy substantially extends the lives of women with advanced breast cancer, scientists announced yesterday. Women with metastatic cancer who were given the combination therapy lived seven months longer than those who were treated with hormones alone. And in women who had previously responded to hormone therapy, these […]

New drug research shows promise in breast cancer study

New drug research shows promise in breast cancer study

FOR the first time, one of the new immunotherapy drugs has shown promise against breast cancer in a large study that combined it with chemotherapy to treat an aggressive form of the disease. But the benefit for most women was small, raising questions about whether the treatment is worth its high cost and side effects. […]

Incyte reports encouraging news on cancer drug licensed to Novartis

Incyte reports encouraging news on cancer drug licensed to Novartis

Incyte Corp. announced promising Phase 2 preliminary results of a clinical trial for a drug that aims to treat a rare type of mutation in lung cancer. Pharma giant Novartis sponsored the study. Results were announced at a conference in Europe. Incyte shares were up 2.5 percent on the news. Our expanding portfolio targets multiple […]

Novartis drug cut death risk by 35 percent in gene mutation breast cancer

Novartis drug cut death risk by 35 percent in gene mutation breast cancer

ZURICH (Reuters) – An experimental cancer drug that Novartis hopes will raise the profile of its oncology portfolio cut the risk of death or disease progression by more than a third in breast cancer patients with a hard-to-target gene mutation. FILE PHOTO: Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern […]

Researchers raise hopes for 'affordable' anti-cancer drug

Researchers raise hopes for 'affordable' anti-cancer drug

People and state-run health agencies have joined a fundraising drive, enabled by social media to help Chulalongkorn University researchers continue their ambitious 1.5-billion-baht research project to develop a new anti-cancer drug. The project hopes to develop an anti-cancer drug in a bid to replace costly imported medicines. The project became the talk of the town […]

Some European countries decide to cover cancer drugs much faster than others

Some European countries decide to cover cancer drugs much faster than others

Some European countries take more than twice as long as others to decide whether to provide reimbursement for new cancer medicines following approval by the European Medicines Agency, according to a study that will be presented at the European Society of Medical Oncology, a gathering of researchers that got underway on Friday in Munich. In […]

1 2 3 158